Uma Menon Sachdeva, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 12 | 2024 | 1648 | 3.090 |
Why?
|
Esophagectomy | 4 | 2023 | 466 | 1.260 |
Why?
|
Adenocarcinoma | 6 | 2024 | 6315 | 0.930 |
Why?
|
Stomach Neoplasms | 2 | 2024 | 1423 | 0.870 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2024 | 600 | 0.800 |
Why?
|
Organoids | 6 | 2024 | 729 | 0.730 |
Why?
|
Neoadjuvant Therapy | 3 | 2023 | 2821 | 0.560 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1347 | 0.540 |
Why?
|
Pneumonectomy | 1 | 2022 | 1111 | 0.510 |
Why?
|
Cell Survival | 3 | 2024 | 5797 | 0.500 |
Why?
|
Precancerous Conditions | 1 | 2021 | 977 | 0.460 |
Why?
|
Cell Lineage | 1 | 2021 | 2533 | 0.400 |
Why?
|
Autophagy | 3 | 2021 | 1337 | 0.380 |
Why?
|
Laparoscopy | 1 | 2023 | 2147 | 0.370 |
Why?
|
Lymph Nodes | 1 | 2022 | 3486 | 0.370 |
Why?
|
Retinoblastoma | 1 | 2012 | 317 | 0.330 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13262 | 0.310 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4319 | 0.310 |
Why?
|
Retinoblastoma Protein | 1 | 2012 | 670 | 0.310 |
Why?
|
Immunotherapy | 2 | 2024 | 4642 | 0.300 |
Why?
|
Cell Physiological Phenomena | 1 | 2008 | 150 | 0.280 |
Why?
|
Esophagus | 2 | 2024 | 1023 | 0.270 |
Why?
|
Colorectal Neoplasms | 2 | 2023 | 6853 | 0.270 |
Why?
|
Polyesters | 1 | 2024 | 372 | 0.210 |
Why?
|
Oxidation-Reduction | 3 | 2024 | 2222 | 0.200 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3844 | 0.190 |
Why?
|
Esophagogastric Junction | 1 | 2023 | 341 | 0.180 |
Why?
|
Racemases and Epimerases | 1 | 2021 | 112 | 0.180 |
Why?
|
Keratinocytes | 2 | 2024 | 792 | 0.180 |
Why?
|
NAD | 1 | 2024 | 609 | 0.180 |
Why?
|
Circadian Rhythm | 2 | 2009 | 2571 | 0.170 |
Why?
|
Cell Proliferation | 6 | 2024 | 10446 | 0.170 |
Why?
|
Oxidative Stress | 2 | 2021 | 3106 | 0.170 |
Why?
|
Lactic Acid | 1 | 2024 | 1134 | 0.160 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2024 | 502 | 0.160 |
Why?
|
Enzyme Activation | 1 | 2024 | 3602 | 0.160 |
Why?
|
Bronchoscopy | 1 | 2024 | 911 | 0.160 |
Why?
|
Obesity | 1 | 2020 | 12922 | 0.150 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 16939 | 0.150 |
Why?
|
Cisplatin | 1 | 2024 | 1644 | 0.150 |
Why?
|
Ethanol | 2 | 2021 | 1323 | 0.150 |
Why?
|
Gastrectomy | 1 | 2023 | 679 | 0.150 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 972 | 0.140 |
Why?
|
Paclitaxel | 1 | 2024 | 1736 | 0.140 |
Why?
|
Humans | 26 | 2024 | 760621 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 725 | 0.130 |
Why?
|
Nanoparticles | 2 | 2024 | 1943 | 0.130 |
Why?
|
Lymph Node Excision | 1 | 2020 | 1303 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2023 | 3529 | 0.120 |
Why?
|
Cell Communication | 1 | 2021 | 1653 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1664 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3306 | 0.110 |
Why?
|
Signal Transduction | 5 | 2024 | 23376 | 0.110 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6131 | 0.110 |
Why?
|
Drug Delivery Systems | 1 | 2024 | 2221 | 0.100 |
Why?
|
Animals | 12 | 2024 | 167963 | 0.100 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1894 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13630 | 0.100 |
Why?
|
Genes, Retinoblastoma | 1 | 2012 | 125 | 0.100 |
Why?
|
Retrospective Studies | 5 | 2023 | 80372 | 0.100 |
Why?
|
Citrates | 1 | 2011 | 135 | 0.100 |
Why?
|
Ketoglutaric Acids | 1 | 2011 | 75 | 0.100 |
Why?
|
Neoplasm Staging | 2 | 2023 | 11152 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2884 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2021 | 2828 | 0.090 |
Why?
|
Combined Modality Therapy | 1 | 2023 | 8552 | 0.090 |
Why?
|
Mitochondria | 2 | 2021 | 3600 | 0.090 |
Why?
|
Societies, Medical | 1 | 2022 | 3905 | 0.090 |
Why?
|
Flavoproteins | 1 | 2009 | 40 | 0.090 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2021 | 296 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2020 | 1287 | 0.080 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2009 | 22 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8515 | 0.080 |
Why?
|
Risk Factors | 3 | 2023 | 74359 | 0.070 |
Why?
|
Databases, Factual | 1 | 2022 | 8035 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4024 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13314 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2011 | 929 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2021 | 11481 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9276 | 0.060 |
Why?
|
Glycolysis | 2 | 2024 | 828 | 0.060 |
Why?
|
Mice | 6 | 2021 | 81208 | 0.060 |
Why?
|
Glucose | 3 | 2011 | 4351 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2934 | 0.060 |
Why?
|
Cell Line | 4 | 2024 | 15620 | 0.050 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2024 | 301 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16546 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 12914 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2023 | 215 | 0.050 |
Why?
|
Prognosis | 1 | 2022 | 29658 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2024 | 695 | 0.050 |
Why?
|
Barrett Esophagus | 1 | 2024 | 490 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2024 | 626 | 0.040 |
Why?
|
Caco-2 Cells | 1 | 2021 | 368 | 0.040 |
Why?
|
HCT116 Cells | 1 | 2021 | 402 | 0.040 |
Why?
|
Drug Carriers | 1 | 2024 | 709 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20509 | 0.040 |
Why?
|
Chemokines | 1 | 2023 | 962 | 0.040 |
Why?
|
Neurodegenerative Diseases | 1 | 2008 | 1084 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 65017 | 0.040 |
Why?
|
Histones | 1 | 2009 | 2583 | 0.040 |
Why?
|
Male | 5 | 2024 | 359744 | 0.040 |
Why?
|
Neoplasm Transplantation | 1 | 2021 | 2014 | 0.040 |
Why?
|
Polymers | 1 | 2024 | 1621 | 0.040 |
Why?
|
Mice, SCID | 1 | 2021 | 2627 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3276 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2021 | 730 | 0.030 |
Why?
|
Female | 4 | 2024 | 391270 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2020 | 1077 | 0.030 |
Why?
|
Aged | 3 | 2024 | 169152 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1928 | 0.030 |
Why?
|
Liver | 1 | 2009 | 7509 | 0.030 |
Why?
|
Protein Kinases | 1 | 2020 | 1612 | 0.030 |
Why?
|
Middle Aged | 3 | 2024 | 220352 | 0.030 |
Why?
|
Fibroblasts | 1 | 2023 | 4090 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18137 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2024 | 3663 | 0.030 |
Why?
|
RNA Interference | 2 | 2011 | 2846 | 0.020 |
Why?
|
Carboxylic Acids | 1 | 2011 | 90 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2011 | 352 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2011 | 193 | 0.020 |
Why?
|
Citric Acid Cycle | 1 | 2011 | 230 | 0.020 |
Why?
|
Cell Nucleus | 2 | 2009 | 2907 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 18957 | 0.020 |
Why?
|
Cryptochromes | 1 | 2009 | 48 | 0.020 |
Why?
|
Acetate-CoA Ligase | 1 | 2009 | 9 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2981 | 0.020 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2009 | 85 | 0.020 |
Why?
|
Ribonucleotides | 1 | 2009 | 114 | 0.020 |
Why?
|
Acetyl Coenzyme A | 1 | 2009 | 75 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2011 | 658 | 0.020 |
Why?
|
ARNTL Transcription Factors | 1 | 2009 | 94 | 0.020 |
Why?
|
Citric Acid | 1 | 2009 | 123 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8651 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3323 | 0.020 |
Why?
|
Glutamine | 1 | 2011 | 576 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2021 | 4013 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9530 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 1649 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8555 | 0.020 |
Why?
|
Models, Biological | 1 | 2024 | 9467 | 0.020 |
Why?
|
Interleukin-3 | 1 | 2009 | 425 | 0.020 |
Why?
|
Protein Stability | 1 | 2009 | 566 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2009 | 492 | 0.020 |
Why?
|
3T3 Cells | 1 | 2009 | 1085 | 0.020 |
Why?
|
Culture Media | 1 | 2009 | 900 | 0.020 |
Why?
|
Mutation | 1 | 2012 | 29932 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5253 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22053 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 1062 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2009 | 1693 | 0.020 |
Why?
|
Lung | 1 | 2024 | 9994 | 0.020 |
Why?
|
Apoptosis | 1 | 2021 | 9501 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1737 | 0.020 |
Why?
|
Food | 1 | 2009 | 771 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 718 | 0.010 |
Why?
|
Cytoplasm | 1 | 2009 | 1516 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2009 | 772 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1139 | 0.010 |
Why?
|
Neoplasms | 2 | 2011 | 22072 | 0.010 |
Why?
|
Adipocytes | 1 | 2009 | 1179 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22023 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8624 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1652 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 3735 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2023 | 15697 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8313 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5785 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54303 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7593 | 0.010 |
Why?
|
United States | 1 | 2023 | 72461 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11903 | 0.010 |
Why?
|